90OThe role of dose-dense (DD) adjuvant chemotherapy (CT) in HER2-positive (HER2+) early breast cancer (BC) patients (pts) before and after the introduction of trastuzumab (T): Exploratory analysis of the GIM2 trial
Lambertini, M, Bruzzone, M, Poggio, F, Conte, B, de Azambuja, E, Bisagni, G, De Laurentiis, M, de Placido, S, Cognetti, F, Del Mastro, LVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz096.004
Date:
May, 2019
File:
PDF, 81 KB
2019